A detailed history of Bergan Kdv Wealth Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 7 shares of DXCM stock, worth $509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 22 68.18%
Holding current value
$509
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$112.47 - $130.98 $1,687 - $1,964
-15 Reduced 68.18%
7 $0
Q4 2022

Jan 31, 2023

SELL
$84.98 - $122.67 $1,019 - $1,472
-12 Reduced 35.29%
22 $2,000
Q3 2022

Oct 24, 2022

SELL
$76.35 - $94.18 $17,560 - $21,661
-230 Reduced 87.12%
34 $3,000
Q2 2022

Jul 13, 2022

BUY
$67.99 - $132.89 $13,597 - $26,577
200 Added 312.5%
264 $20,000
Q4 2020

Feb 04, 2021

BUY
$78.0 - $104.5 $4,446 - $5,956
57 Added 814.29%
64 $24,000
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $438 - $737
7 New
7 $3,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bergan Kdv Wealth Management, LLC Portfolio

Follow Bergan Kdv Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.